Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Uetake

Showing results (131-140 of 206) with videos related to

Pageof 21
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[Resection for the treatment of bleeding caused by ovarian metastasis after hepatectomy for metachronous liver metastasis from sigmoid colon cancer]Hirotoshi Kobayashi, Hiroyuki Uetake, Satoru Iida, et al.
Molecular Cancer|November 5, 2020
The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancerKunitoshi Shigeyasu, Shusuke Toden, Tsuyoshi Ozawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[Three cases of anal squamous cell carcinoma treated with chemoradiotherapy]Yasunori Someno, Toshiaki Ishikawa, Noriko Iwata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 7, 2024
[Long-Term Suppression with First-Line Chemotherapy(FOLFIRI plus BV)for Peritoneal Metastasis]Nobuhisa Teranishi, Shu Inagaki, Hayato Yoshida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2009
[A case of rectal cancer successfully treated by multidisciplinary strategy for liver and pulmonary metastases]Satoshi Okazaki, Hiroyuki Uetake, Makoto Yano, et al.
Anticancer Research|February 10, 2017
Clinical Significance of Methylation and Reduced Expression of the Quaking Gene in Colorectal CancerNoriko Iwata, Toshiaki Ishikawa, Satoshi Okazaki, et al.
Oncology Letters|May 10, 2021
The effectiveness of plasma miR-33a-5p as a predictive biomarker for the efficacy of colorectal cancer chemotherapyMegumi Sasaki, Toshiaki Ishikawa, Megumi Ishiguro, et al.
Annals of Surgical Oncology|February 2, 2008
Messenger RNA expression of vascular endothelial growth factor and its receptors in primary colorectal cancer and corresponding liver metastasisHirotoshi Kobayashi, Kenichi Sugihara, Hiroyuki Uetake, et al.
International Journal of Oncology|March 17, 2009
Messenger RNA expression of COX-2 and angiogenic factors in primary colorectal cancer and corresponding liver metastasisHirotoshi Kobayashi, Kenichi Sugihara, Hiroyuki Uetake, et al.
Molecular and Clinical Oncology|May 27, 2020
Predictors for upstaging of ductal carcinoma <i>in situ</i> (DCIS) to invasive carcinoma in non-mass-type DCISGoshi Oda, Tsuyoshi Nakagawa, Ayumi Ogawa, et al.
Pageof 21

Showing results (131-140 of 206) with videos related to

Sort By:
Pageof 21
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[Resection for the treatment of bleeding caused by ovarian metastasis after hepatectomy for metachronous liver metastasis from sigmoid colon cancer]Hirotoshi Kobayashi, Hiroyuki Uetake, Satoru Iida, et al.
Molecular Cancer|November 5, 2020
The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancerKunitoshi Shigeyasu, Shusuke Toden, Tsuyoshi Ozawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[Three cases of anal squamous cell carcinoma treated with chemoradiotherapy]Yasunori Someno, Toshiaki Ishikawa, Noriko Iwata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 7, 2024
[Long-Term Suppression with First-Line Chemotherapy(FOLFIRI plus BV)for Peritoneal Metastasis]Nobuhisa Teranishi, Shu Inagaki, Hayato Yoshida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2009
[A case of rectal cancer successfully treated by multidisciplinary strategy for liver and pulmonary metastases]Satoshi Okazaki, Hiroyuki Uetake, Makoto Yano, et al.
Anticancer Research|February 10, 2017
Clinical Significance of Methylation and Reduced Expression of the Quaking Gene in Colorectal CancerNoriko Iwata, Toshiaki Ishikawa, Satoshi Okazaki, et al.
Oncology Letters|May 10, 2021
The effectiveness of plasma miR-33a-5p as a predictive biomarker for the efficacy of colorectal cancer chemotherapyMegumi Sasaki, Toshiaki Ishikawa, Megumi Ishiguro, et al.
Annals of Surgical Oncology|February 2, 2008
Messenger RNA expression of vascular endothelial growth factor and its receptors in primary colorectal cancer and corresponding liver metastasisHirotoshi Kobayashi, Kenichi Sugihara, Hiroyuki Uetake, et al.
International Journal of Oncology|March 17, 2009
Messenger RNA expression of COX-2 and angiogenic factors in primary colorectal cancer and corresponding liver metastasisHirotoshi Kobayashi, Kenichi Sugihara, Hiroyuki Uetake, et al.
Molecular and Clinical Oncology|May 27, 2020
Predictors for upstaging of ductal carcinoma <i>in situ</i> (DCIS) to invasive carcinoma in non-mass-type DCISGoshi Oda, Tsuyoshi Nakagawa, Ayumi Ogawa, et al.
Pageof 21